Answers are grounded in this paper and cite their sources.
Canine papillomaviruses (CPVs), members of the Papillomaviridae family, are associated with a spectrum of lesions ranging from oral and cutaneous papillomatosis to pigmented plaques and squamous cell carcinomas (SCCs). Although pigmented plaques in dogs typically remain localized, some cases exhibit widespread dissemination and, in rare instances, progress to malignancy. To date, documented papillomavirus (PV) co-infections in dogs have been limited to interactions between CPV1 and CPV2 from the Lambdavirus and Taupapillomavirus genera. In the present study, we describe a 10-year-old intact male Chinese Crested dog presenting with extensive pigmented plaques and a concurrent SCC. Biopsies were submitted for routine histopathological and molecular analysis. Using rolling-circle amplification (RCA) combined with high-throughput sequencing (HTS), an atypical co-infection involving Chipapillomavirus members CPV8 and CPV9 was identified in pigmented plaques. Subsequent histopathological and phylogenetic analyses of the SCC revealed the presence of CPV8, compatible with a possible association between viral plaques and neoplastic progression. Importantly, both CPV8 and CPV9 encode the oncogenes E6 and E7 , which are known to disrupt critical cellular regulatory pathways. Thus, this first report of a CPV8/CPV9 co-infection in a dog with disseminated viral plaques—where both viruses encode E6 and E7 genes, which in papillomaviruses are associated with cellular transformation —offers a plausible biological context for the observed aggressive neoplasia and raises the hypothesis that co-infections within the Chipapillomavirus genus could be associated with SCC development in some canine patients.
No takes yet. Share an insight, caveat, or question.
Baretta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: